Cancer Home > Liposomal Vincristine Drug Information

Adults who have a certain type of acute leukemia may receive a drug called liposomal vincristine sulfate (Marqibo®). Specifically, it is prescribed to people who have Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). This medication is reserved for use in people who have not had success with at least two previous anti-cancer therapies. It comes as an injection that is given into a vein (intravenously, by IV) once every seven days.
It is common for people to develop some type of reaction to this medication, such as constipation or nausea. Some of the reactions can be quite serious. For example, contact your healthcare provider immediately if you develop an infection, blood in your urine, or an allergic reaction.
If your healthcare provider recommends using liposomal vincristine, he or she will need information on your medical history and any other drugs, vitamins, or supplements you are using. You should also talk to your healthcare provider before starting liposomal vincristine if you are pregnant or have any allergies.
(To learn more about this chemotherapy treatment, click Liposomal Vincristine. This article provides information on how the medicine works, what to expect during treatment, and important warnings and precautions.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.